Production (Stage)
Elevation Oncology, Inc.
ELEV
$0.3817
$0.00150.40%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 80.66M | 93.18M | 103.07M | 110.85M | 104.05M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.54M | 1.54M | 2.25M | 2.72M | 3.84M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 82.19M | 94.73M | 105.32M | 113.57M | 107.89M |
|
|||||
Total Current Assets | 82.19M | 94.73M | 105.32M | 113.57M | 107.89M |
Net Property, Plant & Equipment | 29.00K | 34.00K | 39.00K | 45.00K | 49.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 866.00K | 940.00K | 983.00K | 1.03M |
Total Assets | 82.22M | 95.63M | 106.30M | 114.60M | 108.96M |
|
|||||
Total Accounts Payable | 492.00K | 559.00K | 2.63M | 344.00K | 435.00K |
Total Accrued Expenses | 1.58M | 3.91M | 3.30M | 2.42M | 1.90M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 2.17M | -- | -- | -- | -- |
Total Other Current Liabilities | 2.17M | -- | -- | -- | -- |
Total Current Liabilities | 4.24M | 4.47M | 5.93M | 2.76M | 2.33M |
|
|||||
Total Current Liabilities | 4.24M | 4.47M | 5.93M | 2.76M | 2.33M |
Long-Term Debt | 31.25M | 31.13M | 31.02M | 30.92M | 30.81M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 35.49M | 35.60M | 36.95M | 33.68M | 33.14M |
|
|||||
Common Stock & APIC | 301.51M | 300.53M | 299.35M | 298.18M | 282.58M |
Retained Earnings | -254.67M | -240.46M | -230.02M | -217.14M | -206.68M |
Treasury Stock & Other | -113.00K | -46.00K | 25.00K | -127.00K | -85.00K |
Total Common Equity | 46.73M | 60.03M | 69.36M | 80.92M | 75.82M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 46.73M | 60.03M | 69.36M | 80.92M | 75.82M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 46.73M | 60.03M | 69.36M | 80.92M | 75.82M |
|